Leif Lee
Chief Financial Officer
Replay available
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) Q4 2024 earnings conference call, held 2025-03-25. Replay captured from the company's public earnings webcast.

Chief Financial Officer
Chief Executive Officer
Analyst, Oppenheimer
Analyst, Leidenberg Timeline
Unknown
Analyst, Mizuho Securities
Analyst, Jeffries
Analyst, Cantor
Watch the replay and follow the connected company analysis, news, and investor updates for Corvus Pharmaceuticals, Inc..
WEBVTT 00:00:00.031 -- 00:00:02.614 Good afternoon, everyone. Thank you for standing by. 00:00:02.614 -- 00:00:07.820 And welcome to the Corvus Pharmaceuticals 4th Quarter and Full Year 2024 Business 00:00:07.820 -- 00:00:11.464 Update and Financial Results Conference Call. 00:00:11.464 -- 00:00:14.728 At this time, all participants are in a listen-only mode. 00:00:14.728 -- 00:00:19.193 Later, we will conduct a question-and-answer session, and instructions will follow at 00:00:19.193 -- 00:00:22.416 that time. It is now my pleasure to turn the call over to Mr. 00:00:22.416 -- 00:00:27.520 Zach Kubo of Friel Chemistry. Thank you. Please go ahead, sir. 00:00:27.605 -- 00:00:30.068 Thank you, Operator, and good afternoon, everyone. 00:00:30.068 -- 00:00:35.716 Thanks for joining us for the Corvus Pharmaceuticals' fourth quarter and full year 2024 00:00:35.716 -- 00:00:39.160 Business Update and Financial Results Conference Call. 00:00:39.160 -- 00:00:43.265 On the call to discuss the results and business updates are Richard Miller, Chief Executive 00:00:43.265 -- 00:00:48.652 Officer, Leif Lee, Chief Financial Officer, Jeff Arcarra, Chief Business Officer, 00:00:48.652 -- 00:00:53.812 and Ben Jones, Senior Vice President of Regulatory and Pharmaceutical Sciences. 00:00:53.812 -- 00:00:57.658 The executive team will open the call with some prepared remarks followed by a question 00:00:57.658 -- 00:00:59.461 and answer period. 00:00:59.461 -- 00:01:03.027 I would like to remind everyone that comments made by management today and answers to 00:01:03.027 -- 00:01:05.892 questions will include forward-looking statements. 00:01:05.892 -- 00:01:09.858 Forward-looking statements are based on estimates and assumptions as of today and are 00:01:09.858 -- 00:01:14.265 subject to ...